Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.06 Billion INR | 988.44% |
| 2022 | 97.61 Million INR | 118.26% |
| 2021 | -534.69 Million INR | -125.82% |
| 2020 | 2.07 Billion INR | -7.48% |
| 2019 | 2.23 Billion INR | 39.29% |
| 2018 | 1.6 Billion INR | -26.74% |
| 2017 | 2.19 Billion INR | 641.14% |
| 2016 | 295.97 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.57 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | 1.08 Billion INR | 1014.6% |
| 2023 Q2 | 797.35 Million INR | -26.71% |
| 2023 FY | 1.06 Billion INR | 988.44% |
| 2023 Q4 | 1.06 Billion INR | -47.54% |
| 2023 Q3 | 2.02 Billion INR | 153.99% |
| 2022 FY | 97.61 Million INR | 118.26% |
| 2022 Q1 | 2.41 Billion INR | 552.38% |
| 2022 Q4 | 97.61 Million INR | -94.31% |
| 2022 Q3 | 1.71 Billion INR | 349.07% |
| 2022 Q2 | 381.77 Million INR | -84.22% |
| 2021 Q1 | 1.52 Billion INR | -26.17% |
| 2021 FY | -534.69 Million INR | -125.82% |
| 2021 Q4 | -534.69 Million INR | -114.08% |
| 2021 Q3 | 3.79 Billion INR | 2474.75% |
| 2021 Q2 | 147.48 Million INR | -90.36% |
| 2020 Q4 | 2.07 Billion INR | 0.0% |
| 2020 FY | 2.07 Billion INR | -7.48% |
| 2019 Q4 | 7.17 Billion INR | 0.0% |
| 2019 FY | 2.23 Billion INR | 39.29% |
| 2018 FY | 1.6 Billion INR | -26.74% |
| 2017 FY | 2.19 Billion INR | 641.14% |
| 2016 FY | 295.97 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | -5.83 Billion INR | 118.211% |
| Metropolis Healthcare Limited | 1.25 Billion INR | 15.579% |
| Thyrocare Technologies Limited | 24.5 Million INR | -4236.449% |
| Vijaya Diagnostic Centre Limited | 1.86 Billion INR | 42.912% |
| Vimta Labs Limited | -66 Million INR | 1709.742% |